COSCIENS Biopharma Inc. (CSCI) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Apr 21Apr 24Apr 29May 4May 13May 18May 21Jul 7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.1x

Market Cap

$8.64M

MomentumView details →

1D Return

+0.00%

YTD Return

+32.04%

RSI (14)

76.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.1x

Market Cap

$8.64M

RSI (14)

76.3

MomentumView details →

1D Return

+0.00%

YTD Return

+32.04%

ProfitabilityView details →

Gross Margin

45.58%

Net Margin

−199.53%

EBITDA Margin

−172.08%

ROE (TTM)

−265.34%

ROA (TTM)

−68.33%

Asset Turnover

0.32x

GrowthView details →

Revenue YoY

+22.07%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+0.73%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.85

EPS Surprise

—

Beats (12Q)

2/12

Next Q EPS Est

—

Avg Surprise (4Q)

−23.98%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.32x

Current Ratio

2.98x

Quick Ratio

2.65x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

9.44M

Net Income (TTM)

−18.83M

Op. CF (TTM)

−17.10M

Latest newsMore news →

COSCIENS Biopharma Inc. reported a net loss of $202,000 for its second quarter, with revenue of $3.1 million.24d ago

Similar companies

CDT Equity Inc.CDT Skye Bioscience, Inc.SKYE Evogene Ltd.EVGN Cuprina Holdings (Cayman) Limited Class A Ordinary SharesCUPR Traws Pharma, Inc.TRAW Imunon, Inc.IMNN Find similar companies →

Latest newsMore news →

COSCIENS Biopharma Inc. reported a net loss of $202,000 for its second quarter, with revenue of $3.1 million.24d ago